Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats.

Raleigh MD, Laudenbach M, Baruffaldi F, Peterson SJ, Roslawski MJ, Birnbaum AK, Carroll FI, Runyon SP, Winston S, Pentel PR, Pravetoni M.

J Pharmacol Exp Ther. 2018 Mar 13. pii: jpet.117.247049. doi: 10.1124/jpet.117.247049. [Epub ahead of print]


Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.

Raleigh MD, Peterson SJ, Laudenbach M, Baruffaldi F, Carroll FI, Comer SD, Navarro HA, Langston TL, Runyon SP, Winston S, Pravetoni M, Pentel PR.

PLoS One. 2017 Dec 1;12(12):e0184876. doi: 10.1371/journal.pone.0184876. eCollection 2017.


Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Avogadri F, Gnjatic S, Tassello J, Frosina D, Hanson N, Laudenbach M, Ritter E, Merghoub T, Busam KJ, Jungbluth AA.

Am J Dermatopathol. 2016 Mar;38(3):201-7. doi: 10.1097/DAD.0000000000000362.


The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.

Laudenbach M, Tucker AM, Runyon SP, Carroll FI, Pravetoni M.

Vaccine. 2015 Nov 17;33(46):6332-9. doi: 10.1016/j.vaccine.2015.09.015. Epub 2015 Sep 26.


The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.

Laudenbach M, Baruffaldi F, Vervacke JS, Distefano MD, Titcombe PJ, Mueller DL, Tubo NJ, Griffith TS, Pravetoni M.

J Immunol. 2015 Jun 15;194(12):5926-36. doi: 10.4049/jimmunol.1500385. Epub 2015 May 13.


Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.

Pravetoni M, Vervacke JS, Distefano MD, Tucker AM, Laudenbach M, Pentel PR.

PLoS One. 2014 May 5;9(5):e96547. doi: 10.1371/journal.pone.0096547. eCollection 2014.


Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.

Taylor JJ, Laudenbach M, Tucker AM, Jenkins MK, Pravetoni M.

J Immunol Methods. 2014 Mar;405:74-86. doi: 10.1016/j.jim.2014.01.010. Epub 2014 Jan 23.

Supplemental Content

Loading ...
Support Center